Caxton Associates (New York)’s Zimmer Biomet ZBH Stock Holding History

Caxton Associates (New York)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,534	Closed	-$239K	–	617
2021 Q2	$239K	Buy	+1,534	New	+$248K	0.03%	376
2020 Q1	–	Sell	-36,050	Closed	-$5.24M	–	616
2019 Q4	$5.24M	Buy	+36,050	New	+$4.98M	0.72%	24
2019 Q1	–	Sell	-2,028	Closed	-$204K	–	506
2018 Q4	$204K	Buy	+2,028	New	+$228K	0.03%	244
2018 Q2	–	Sell	-6,502	Closed	-$688K	–	496
2018 Q1	$688K	Buy	+6,502	New	+$755K	0.04%	232
2017 Q2	–	Sell	-3,399	Closed	-$403K	–	587
2017 Q1	$403K	Buy	+3,399	New	+$385K	﹤0.01%	308

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Caxton Associates (New York)'s ZBH Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,534 shares — an estimated $239K sold.

Caxton Associates (New York) first reported a position in ZBH in Q1 2017 and held it in 5 quarters. The position peaked at $5.24M in Q4 2019. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Caxton Associates (New York) reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Caxton Associates (New York) sold 1,534 Zimmer Biomet shares in Q3 2021, an estimated $239K.
Caxton Associates (New York) first reported a position in Zimmer Biomet in Q1 2017 and held it in 5 quarters.
Caxton Associates (New York)'s Zimmer Biomet position peaked at $5.24M in Q4 2019.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.